Abstract
The study of pituitary thyroid relationships of a 40 - year-old woman, suffering from recurrent goiter, is presented. The characteristics of this case were the following: i) constant hyperthyrotropinemia (range 8.2 to 29 μU/ml) despite high thyroid hormone levels (mean total T4: 13.4 μg/dl; mean total T3: 255 ng/dl) and clinical euthyroidism; ii) thisTSH hypersecretion is not regulated by an excess of T4, while a suppressive effect is easily observed with T3. Together with the clinical effects observed with administration of T3 and T4, this suggests that thyroid hormone resistance predominates at the pituitary level, for T4 while not for T3; iii) evidence is presented for the familial distribution of the trait and its mode of transmission. The clinical aspect and the pattern of resistance exhibited by the propositus and her progeny appear distinct from those of previous observations of thyroid hormone resistance.
Similar content being viewed by others
References
Jailer J.W., Holub DA Remission of Graves’ disease following radioteherapy of a pituitary neoplasm. Am. J. Med. 28: 497, 1960.
Lamberg B.A., Ripatti A.G., Juustila H., Sivula A., Björkesten G. Chromophobe pituitary adenoma with acromegaly and TSH-induced hyperthyroidism associated with parathyroid adenoma. Acta Endocrinol. (Kbh.) 60: 157, 1969.
Hamilton CR., Adams L.C., Maloof F. Hyperthyroidism due to thyrotropin-producing pituitary chromophobe adenoma. N. Engl. J. Med. 283: 1077, 1970.
Faglia G., Ferrari C., Neri V., Beck-Peccoz P., Ambrosi B., Valentini F. High plasma thyrotropin levels in two patients with pituitary tumor. Acta Endocrinol. (Kbh.) 69: 649, 1972.
Mornex R., Tommasi M., Cure M., Farcot J., Orgiazzi J., Rousset B. Hyperthyroide associée à un hypopituitarisme au cours de l’évolution d’une tumeur hypophysarie sécrétant TSH. Ann. Endocrinol. (Paris) 33: 390, 1972.
Emerson C.H., Utiger R.D. Hyperthyroidism and excessive thyrotropin secretion. N. EngL J. Med. 287: 328, 1972.
O’Donnell J., Hadden R.D., Weaver J.A. Thyrotoxicosis recurring after surgical removal of a thy rotropin pituitary adenoma Proc. R. Soc. Med. 66: 441, 1973.
Horn K., Erhardt F., Fahlbusch R., Pickardt C.R., Werder K.V., Scriba P.C. Recurrent goiter, hyperthyroidism, galactorrhea and amenorrhea due to thyrotropin and prolactin-producing pituitary tumor. J. Clin. Endocrinol. Metab. 43: 137, 1976.
Smallridge R.C., Wartofsky L, Dimond R.C. Inappropriate secretion of thyrotropin: discordance between the suppressive effects of corticosteroids and thyroid hormones. J. Clin. Endocrinol. Metab. 48: 700, 1979.
Waldhäusl W., Bratusch-Marrain P., Nowotny P., Büchler M., Forssmann W.G., Lujf A., Schuster H. Secondary hyperthyroidism due to thyrotrpin hypersecretion: study of pituitary tumor morphology and thyrotropin chemistry and release. J. Clin. Endocrinol. Metab. 49: 879, 1979.
Refetoff S., DeGroot L.J., Benard B., De Wind L.T. Studies of a sibship with apparent hereditary resistance to the intracellular action of thyroid hormone. Metabolism 21: 723, 1972.
Agerbaek H. Congenital goiter presumably resulting from tissue resistance to thyroid hormone. Isr. J. Med. Sci. 8: 1859, 1972.
Lamberg B.A. Congenital euthyroid goiter and partial peripheral resistance to thyroid hormones. Lancet 1: 854, 1973.
Bode H.H., Danon M., Weintraub B.D., Maloof F., Crawford J.D. Partial target-organ resistance to thyroid hormone. J. Clin. Invest. 52: 776, 1973.
Schneider G., Keiser H.R., Bardin C.W. Peripheral resistance to thyroxine: a cause of short stature in a boy without goitre. Clin. Endocrinol. (Oxf.) 4: 111, 1975.
Gershengorn M.C., Weintraub B.D. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of “inappropriate secretion of TSH”. J. Clin. Invest. 56: 633, 1975.
Elewaut A., Mussche M., Vermeulen A. Familial partial target organ resistance to thyroid hormones. J. Clin. Endocrinol. Metab. 43: 375, 1976.
Hood S., Vaughan-Jackson J.D., Farid N.D. Inappropriate TSH secretion. Paradoxical use in serum TSH in response to thyroxine therapy. J. Clin. Endocrinol. Metab. 43: 1360, 1976.
Novogroder M., Utiger R., Boyar R., Levine L.S. Juvenile hyperthyroidism with elevated thyrotropin (TSH) and normal 24 hours FSH, LH, GH and prolactin secretory patterns. J. Clin. Endocrinol. Metab. 45: 1053, 1977.
Lamberg B.A., Rosengard S., Liewendhahl K., Saarinen P., Evered D.C. Familial partial peripheral resistance to thyroid hormones. Acta Endocrinol. 87: 303, 1978.
Seif F.J., Scherbaum W., Klingler W. Syndrome of elevated thyroid hormone and TSH blood levels. A case report. Acta Endocrinol. (Kbh.) 87: (Suppl. 215): 81, 1978.
Tamagna E., Carlson H., Hershman J.M., Reed A. Pituitary and peripheral resistance to thyroid hormones. Clin. Endocrinol. (Oxf.) 10: 431, 1979.
Daubresse J.C., Dozin-van Roye B., De Nayer Ph., De Visscher M. Partial resistance to thyroid hormones: reduced affinity of lymphocyte nuclear receptors for T3 in two siblings. In: Stockigt J.R., Nagataki S. (Eds.), Thyroid reseach VIII. Australian Academy of Science, Sidney, 1980, p. 295.
Barker S.B., Humphrey M.J., Soley M.H. The clinical determination of protein-bound-iodine. J.Clin. Invest. 30: 55, 1951.
Vandalem J.L., Ketelslegers J.M., Pirens G., Closset J., Hennen G. Dosage radioimmunologique de l’hormone thyréostimulante. Etude immunologique du système et application clinique. Acta Clin. Belg. 30: 521, 1975.
Vandalem J.L., Pirens G., Closset J., Hennen G. Selective radioimmunoassays for human luteinizing hormone (hLH) and human chorionic gonadotropin (hCG). Arch. Int. Physiol. Biochim. 83: 753, 1975.
Vandalem J.L., Pirens G., Hennen G., Gaspard U. Thyroliberin and gonadoliberin tests during pregnancy and the Puerperium. Acta Endocrinol. (Kbh.) 86: 695, 1977.
Closset J., Vandalem J.L., Hennen G., Lequin R.M. Human luteinizing hormone. Isolation and characterization of the native hormone and its alpha and beta subunits. Eur. J. Biochem. 57: 325, 1975.
Hennen G., Vandalem J.L., Pirens G., Closset J., Maghuin-Rogister G. Glycoprotein hormone: molecular characteristics and specific measurements during pregnancy. In: Peeters H. (Ed.), Protides of biological fluids. Pergamon Press, Brugge, 1976, p. 53.
McKenzie J.M., Zakarija M. A reconsideration of a thyroid-stimulating immunoglobulin as the cause of hyperthyroidism in Graves’ disease. J. Clin. Endocrinol. Metab. 42: 778, 1976.
Maghuin-Rogister G., Closset J., Combarnous Y., Hennen G., Dechenne C., Ketelslegers J.M. Studies of FSH receptors in testing using a homologous system. Binding of porcine follitropin to plasma membrane from immature porcine testis and correlation with adenylate cyclase stimulation. Eur. J. Biochem. 86: 121, 1978.
Golstein-Golaire J., Vanhaelst L. Gel filtration profile of circulating immunoreactive thyrotropin and subunits of myxoedematous sera. J. Clin. Endocrinol. Metab. 41: 575, 1975.
Kourides I.A., Weintraub B.D., Maloof F. Large molecular weight TSH-beta: the sole immunoac-tive form of TSH beta in certain human sera. J. Clin. Endocrinol. Metab. 47: 24, 1978.
Erhardt F.W., Scriba P.C. High molecular weight thyrotropin (“Big” TSH) from human pituitaries: preparation and partial characterization. Acta Endocrinol. (Kbh.) 85: 698, 1977.
Vanhaelst L., Golstein-Golaire J. Gel filtration profile of immunoreactive thyrotropin and subunits on human pituitaries. J. Clin. Endocrinol. Metab. 43: 836, 1976.
Tager H., Given B., Baldwin D., Mako M., Markese J., Rubenstein A., Olefsky J., Kobayashi M., Kolterman O., Poucher R. A structurally abnormal insulin causing human diabetes. Nature 281: 122, 1979.
Axelrod L., Neer R.M., Kliman B. Hypogonadism in a male with immunologically active, biologically inactive luteinizing hormone: an exception to a venerable rule. J. Clin. Endocrinol. Metab. 48: 279, 1979.
Faglia G., Bitensky L., Pinchera A., Ferrari C., Paracchi A., Beck-Peccoz P., Ambrosi B., Spada A. Thyrotropin secretion in patients with central hypothy roidism: evidence for reduced biological activity of immunoactive thyrotropin. J. Clin. Endocrinol. Metab. 48: 989, 1979.
Kourides I.A., Weintraub B.D., Rosen S.W., Ridgway E.C., Kliman G., Maloof F. Secretion of alpha subunit of glycoprotein hormones by pituitary adenomas. J. Clin. Endocrinol. Metab. 43: 97, 1976.
Kourides I.A., Ridgway E.C., Weintraub B.D., Bigos S.T., Gershengorn M.C., Maloof F. Thyrotropin induced hyperthyroidism: use of alpha and beta subunits levels to identify patients with pituitary tumors. J. Clin. Endocrinol. Metab. 45: 534, 1977.
Refetoff S., De Wind L.T., DeGroot L.J. Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormally high PBI: Possible target organ refractoriness to thyroid hormone. J. Clin. Endocrinol. Metab. 27: 279, 1967.
Bernal J., Refetoff S., DeGroot L.J. Abnormalities of triiodothyronine binding to lymphocyte and fibroblast nuclei from a patient with peripheral tissue resistance to thyroid hormone action. J. Clin. Endocrinol. Metab. 47: 1266, 1978.
Wenzel K.W., Meinhold H., Schleusener H. Different effects of oral doses of triiodothyronine or thyroxine on the inhibition of thyrotropin releasing hormone (TRH) mediated thyrotropin (TSH) response in man. Acta Endocrinol. (Kbh.) 80: 42, 1975.
Sawin C.T., Hershman J.M., Chopra I.J. The comparative effect of T4 and T3 on TSH response to TRH in young adult men. J. Clin. Endocrinol. Metab. 44: 273, 1977.
Kourides I.A., Ridgway E.C., Maloof F. Discordant response of thyrotropin and its free alpha and beta subunits after thyrotropin-releasing hormone with incremental thyroid hormone replacement in primary hypothyroidism. J. Clin. Endocrinol. Metab. 49: 700, 1979.
Krugman L.G., Hershman J.M., Chropra I.J., Levine G.A., Pekary A.E., Geffner D.L., Chua Teco G.N. Patterns od recovery of the hypothalamic-pituitary-thy-roid axis in patients taken off chronic thyroid therapy. J. Clin. Endocrinol. Metab. 41: 70, 1975.
Vagenakis A.G., Braverman L.E., Azizi F., Portnay G.J., Ingbar S.H. Recovery of pituitary thyrotropic function after withdrawal of prolonged thyroid-suppression therapy. N. Engl. J. Med. 293: 681, 1975.
Nilson G., Petterson V., Levin K., Hughes R. Studies on replacement and suppressive dosages of L-thyroxine. Acta Med. Scand. 202: 257, 1977.
Cotton G.E., Gorman C.A., Mayberry W.E. Suppression of thyrotropin (hTSH) in serums of patients with myxoedema of varying etiology treated with thyroid hormones. N. Engl. J. Med. 285: 529, 1971.
Evered D., Young E.T., Ormston B.J., Menzies R., Smith P.A., Hall R. Treatment of hypothyroidism: A reappraisal of thyroxine therapy. Med. J. 3: 131, 1973.
Stock J.M., Surks M.I., Oppenheimer J.H. Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation. N. Engl. J. Med. 290: 529, 1974.
Riesco G., Taurog A., Larsen P.R. Variations in the response of the thyroid gland of the rat to different low-iodine diets: correlation with iodine content of diet. Endocrinology 99: 270, 1976.
Silva J.E., Larsen P.R. Pituitary nuclear 3,5,3′-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science 198: 617, 1977.
Silva J.E., Larsen P.R. Contributions of plasma triiodothyronine and local thyroxine monodeiodination to triiodothyronine to nuclear triiodothyronine receptor saturation in pituitary, lever and kidney of hypothyroid rats. Further evidence relating saturation of pituitary nuclear triiodothyronine receptor and the acute inhibition of thyroid-stimulating hormone release. J. Clin. Invest. 61: 1247, 1978.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vandalem, J.L., Pirens, G. & Hennen, G. Familial inappropriate TSH secretion: evidence suggesting a dissociated pituitary resistance to T3 and T4 . J Endocrinol Invest 4, 413–422 (1981). https://doi.org/10.1007/BF03348305
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348305